BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin YL, Chen CH, Wu HY, Tsai NM, Jian TY, Chang YC, Lin CH, Wu CH, Hsu FT, Leung TK, Liao KW. Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex. J Nanobiotechnology 2016;14:11. [PMID: 26892504 DOI: 10.1186/s12951-016-0163-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kathle PK, Gautam N, Kesavan K. Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study. Journal of Microencapsulation 2018;35:292-300. [DOI: 10.1080/02652048.2018.1477844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gubala V, Johnston LJ, Krug HF, Moore CJ, Ober CK, Schwenk M, Vert M. Engineered nanomaterials and human health: Part 2. Applications and nanotoxicology (IUPAC Technical Report). Pure and Applied Chemistry 2018;90:1325-56. [DOI: 10.1515/pac-2017-0102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Chang KF, Chang JT, Huang XF, Lin YL, Liao KW, Huang CW, Tsai NM. Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells. Molecules 2020;25:E2394. [PMID: 32455622 DOI: 10.3390/molecules25102394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Stefanov SR, Andonova VY. Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals (Basel) 2021;14:1083. [PMID: 34832865 DOI: 10.3390/ph14111083] [Reference Citation Analysis]
5 Mojeiko G, Passos JS, Apolinário AC, Lopes LB. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us? Nanomedicine (Lond) 2021;16:1713-31. [PMID: 34256574 DOI: 10.2217/nnm-2021-0130] [Reference Citation Analysis]
6 Jose A, Ninave KM, Karnam S, Venuganti VVK. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment. J Liposome Res 2019;29:153-62. [PMID: 30022700 DOI: 10.1080/08982104.2018.1502315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lin YL, Huang XF, Chang KF, Liao KW, Tsai NM. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine 2020;15:749-60. [PMID: 32099363 DOI: 10.2147/IJN.S235815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Chang KF, Huang XF, Lin YL, Liao KW, Hsieh MC, Chang JT, Tsai NM. Positively Charged Nanoparticle Delivery of n-Butylidenephthalide Enhances Antitumor Effect in Hepatocellular Carcinoma. Biomed Res Int 2021;2021:8817875. [PMID: 33791383 DOI: 10.1155/2021/8817875] [Reference Citation Analysis]
9 Chang YC, Lin CH, Lin JC, Cheng SP, Chen SN, Liu CL. Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer. J Surg Res 2019;241:8-14. [PMID: 31004874 DOI: 10.1016/j.jss.2019.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Gao HW, Chang KF, Huang XF, Lin YL, Weng JC, Liao KW, Tsai NM. Antitumor Effect of n-Butylidenephthalide Encapsulated on B16/F10 Melanoma Cells In Vitro with a Polycationic Liposome Containing PEI and Polyethylene Glycol Complex. Molecules 2018;23:E3224. [PMID: 30563276 DOI: 10.3390/molecules23123224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hussein HA, Abdullah MA. Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment. Appl Nanosci. [DOI: 10.1007/s13204-021-02018-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Day CM, Hickey SM, Song Y, Plush SE, Garg S. Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles. Molecules. 2020;25. [PMID: 32151063 DOI: 10.3390/molecules25051182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
13 Huang XF, Chang KF, Lin YL, Liao KW, Hsiao CY, Sheu GT, Tsai NM. Enhancement of cytotoxicity and induction of apoptosis by cationic nano-liposome formulation of n-butylidenephthalide in breast cancer cells. Int J Med Sci 2021;18:2930-42. [PMID: 34220320 DOI: 10.7150/ijms.51439] [Reference Citation Analysis]
14 Guney Eskiler G, Cecener G, Dikmen G, Egeli U, Tunca B. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer. Eur J Pharm Sci 2018;120:73-88. [PMID: 29719240 DOI: 10.1016/j.ejps.2018.04.040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
15 Farshbaf M, Davaran S, Zarebkohan A, Annabi N, Akbarzadeh A, Salehi R. Significant role of cationic polymers in drug delivery systems. Artif Cells Nanomed Biotechnol 2018;46:1872-91. [PMID: 29103306 DOI: 10.1080/21691401.2017.1395344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Jiang Y, Jiang Z, Wang M, Ma L. Current understandings and clinical translation of nanomedicines for breast cancer therapy. Adv Drug Deliv Rev 2022;180:114034. [PMID: 34736986 DOI: 10.1016/j.addr.2021.114034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Neupane R, Boddu SHS, Abou-Dahech MS, Bachu RD, Terrero D, Babu RJ, Tiwari AK. Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities. Pharmaceutics 2021;13:960. [PMID: 34206728 DOI: 10.3390/pharmaceutics13070960] [Reference Citation Analysis]
18 Kumar P, Kumar R, Singh B, Malik R, Sharma G, Chitkara D, Katare OP, Raza K. Biocompatible Phospholipid-Based Mixed Micelles for Tamoxifen Delivery: Promising Evidences from In - Vitro Anticancer Activity and Dermatokinetic Studies. AAPS PharmSciTech 2017;18:2037-44. [PMID: 27966177 DOI: 10.1208/s12249-016-0681-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
19 Chao X, Zhao L, Ma N, Mou Y, Zhang P. Nanotechnology-based drug delivery systems for the improved sensitization of tamoxifen. Journal of Drug Delivery Science and Technology 2021;61:102229. [DOI: 10.1016/j.jddst.2020.102229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhong X, Di Z, Xu Y, Liang Q, Feng K, Zhang Y, Di L, Wang R. Mineral medicine: from traditional drugs to multifunctional delivery systems. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00577-9] [Reference Citation Analysis]
21 Lee JJ, Saiful Yazan L, Che Abdullah CA. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment. Int J Nanomedicine 2017;12:2373-84. [PMID: 28392694 DOI: 10.2147/IJN.S127329] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 7.4] [Reference Citation Analysis]